Related Articles
Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: A phase II trial
Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma.
Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: Long-term prognosis after five years
Interleukin-2 and 13-cis retinoic acid in the treatment of minimal residual disease: A phase II study